Home

Mankind Pharma Ltd Quarterly Result

Image

Mankind Pharma Ltd

NSE: MANKIND

Net Profit - Last Quarter

₹ 658.88 Cr.

Last updated on: Jan 22, 2025

Mankind Pharma Ltd Quarterly Results Key Highlights

  • The revenue of Mankind Pharma Ltd for the Sep '24 is ₹ 3188 crore as compare to the Jun '24 revenue of ₹ 2997 crore.
  • This represent the growth of 6.36%a1# The ebitda of Mankind Pharma Ltd for the Sep '24 is ₹ 962.04 crore as compare to the Jun '24 ebitda of ₹ 786.27 crore.
  • This represent the growth of 22.35%a1# The net profit of Mankind Pharma Ltd for the Sep '24 is ₹ 658.88 crore as compare to the Jun '24 net profit of ₹ 543.07 crore.
  • This represent the growth of 21.33%a1#.

Mankind Pharma Ltd Quarterly Results Analysis

Market Price of Mankind Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Mankind Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Jan 20252515.05
21 Jan 20252563.35
20 Jan 20252705.3
17 Jan 20252600.15
16 Jan 20252547.85
15 Jan 20252595.4
14 Jan 20252671.45
13 Jan 20252590.6
10 Jan 20252738.25
09 Jan 20252828.85

Historical Revenue of Mankind Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Mankind Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Mankind Pharma Ltd

No data available

* All values are in crore

Mankind Pharma Ltd News Hub

Mankind Pharma allots 9000 equity shares under ESOP

Mankind Pharma has allotted 9000 equity shares under ESOP on 14 August 2024. Consequent to the afore

Read more

14 Aug 2024

Mankind Pharma Ltd gains for fifth session

Mankind Pharma Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 2150.3, u

Read more

12 Aug 2024

Mankind Pharma Ltd soars 1.03%

Mankind Pharma Ltd is up for a third straight session in a row. The stock is quoting at Rs 2079.3, u

Read more

08 Aug 2024

Mankind Pharma to transfer its OTC business to Mankind Consumer Products

Mankind Pharma has executed the Business Transfer Agreement (BTA) on 03 September 2024 to transfer O

Read more

03 Sep 2024

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

July 2024

PPT

Jan 2024

PPT

June 2023

TranscriptPPT

FAQs for Quarterly Results of Mankind Pharma Ltd

What key financial metrics are included in Mankind Pharma Ltd's quarterly results?

Key financial metrics in Mankind Pharma Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Mankind Pharma Ltd announce its quarterly results?

Mankind Pharma Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Mankind Pharma Ltd's quarterly performance impact its stock price?

Mankind Pharma Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Mankind Pharma Ltd's quarterly results on dividends?

The impact of Mankind Pharma Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Mankind Pharma Ltd's quarterly results?

Yes, Mankind Pharma Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions